AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. 詳細を表示
HUNTSVILLE, AL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...
HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...
HUNTSVILLE, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.96 | 15.9468438538 | 6.02 | 7.49 | 6.02 | 9739 | 6.88758579 | CS |
4 | -0.07 | -0.992907801418 | 7.05 | 10.28 | 5.79 | 21533 | 7.53838549 | CS |
12 | -2.42 | -25.7446808511 | 9.4 | 11.565 | 5.79 | 17398 | 8.13148677 | CS |
26 | -4.52 | -39.3043478261 | 11.5 | 14.57 | 5.79 | 16355 | 8.62975368 | CS |
52 | -4.7 | -40.2397260274 | 11.68 | 19.93 | 5.79 | 16181 | 8.84581903 | CS |
156 | -4.7 | -40.2397260274 | 11.68 | 19.93 | 5.79 | 16181 | 8.84581903 | CS |
260 | -4.7 | -40.2397260274 | 11.68 | 19.93 | 5.79 | 16181 | 8.84581903 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約